A Study of ELX-02 in Patients With Alport Syndrome

NCT05448755 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eloxx Pharmaceuticals, Inc.